|
protic solvent
|
CHEBI_48356 |
|
|
Bronsted acid
|
CHEBI_39141 |
|
|
non-polar solvent
|
CHEBI_48355 |
|
|
antitrichomonal drug
|
CHEBI_50685 |
|
|
serine proteinase inhibitor
|
CHEBI_48353 |
|
|
EC 3.5.1.108 (UDP-3-O-acyl-N-acetylglucosamine deacetylase) inhibitor
|
CHEBI_134109 |
|
|
antithyroid drug
|
CHEBI_50671 |
|
|
pemphigus
|
DOID_9182 |
|
|
bullous skin disease
|
DOID_8502 |
|
|
autoimmune disease of musculoskeletal system
|
DOID_0060032 |
|
|
amebiasis
|
DOID_9181 |
|
|
parasitic protozoa infectious disease
|
DOID_2789 |
|
|
VEGF activator
|
CHEBI_91189 |
|
|
eye lymphoma
|
DOID_6903 |
|
|
amphiprotic solvent
|
CHEBI_48360 |
|
|
multichannel ion channel screening
|
BAO_0013048 |
|
|
safety pharmacology assay
|
BAO_0002533 |
|
|
Caspase-Glo 6 Assay System (Promega)
|
BAO_0140030 |
|
|
telemetry ECG in conscious animals
|
BAO_0013049 |
|
|
QT interval assay
|
BAO_0002184 |
|
